Seidel Ronald D. III 4
4 · Cue Biopharma, Inc. · Filed Jul 25, 2018
Insider Transaction Report
Form 4
Seidel Ronald D. III
EVP, Head of R&D
Transactions
- Award
Stock Option (right to buy)
2018-07-23+75,000→ 75,000 totalExercise: $11.54Exp: 2025-07-23→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in eight semi-annual installments beginning July 23, 2018.